Related Experiment Video
Updated: Jun 23, 2025

Synergetic Use of Neural Precursor Cells and Self-assembling Peptides in Experimental Cervical Spinal Cord Injury
Published on: February 23, 2015
Inhibition of CSPG-PTPσ Activates Autophagy Flux and Lysosome Fusion, Aids Axon and Synaptic Reorganization in Spinal
Hongyu Wang1,2,3,4, Naibo Feng5,6, Chungeng Liu5,6
1The First Affiliated Hospital (Shenzhen People's Hospital), Southern University of Science and Technology, Shenzhen, 518055, China. wanghongyu790039663@126.com.
Abstract:
Chondroitin sulfate proteoglycans (CSPGs) and proteoglycan receptor protein tyrosine phosphatase σ (PTPσ) play a critical role in the pathology of spinal cord injury (SCI). CSPGs can be induced by autophagy inhibition in astrocyte. However, CSPG's impact on autophagy and its role in SCI is still unknown. We investigate intracellular sigma peptide (ISP) targeting PTPσ, its effects on autophagy, and synaptic reorganization in SCI. We found that ISP increased the level of autophagosome marker LC3B-II/I and decreased autophagosome degradation marker p62 in SCI, suggesting activated autophagy flux. ISP restored autophagosome-lysosome fusion-related protein syntaxin 17 (STX17) and lysosome-associated membrane protein 2 (LAMP2), indicating activated autophagosome-lysosome fusion. ISP increased pre-synaptic marker synaptophysin (SYN) and postsynaptic density protein-95 (PSD-95) expression and improved excitatory synapse marker vesicular glutamate transporter 1 (VGLUT1) and SYN in SCI, suggesting improved synaptic reorganization. ISP promoted axon marker neurofilament and growth-related GAP-43 expression in SCI. ISP rescued a preserved number of motor neurons and improved neurobehavioral recovery after SCI. Our study extended the CSPG-PTPσ inhibition role in activating autophagy flux, axon and synaptic reorganization, and functional recovery in SCI.
Insights
Intracellular sigma peptide (ISP) activates autophagy and promotes synaptic reorganization after spinal cord injury (SCI). This treatment improves motor neuron survival and functional recovery, highlighting a new therapeutic avenue for SCI.
Area of Science:
- Neuroscience
- Cell Biology
- Regenerative Medicine
Background:
- Chondroitin sulfate proteoglycans (CSPGs) and their receptor protein tyrosine phosphatase σ (PTPσ) are implicated in spinal cord injury (SCI) pathology.
- Autophagy inhibition can induce CSPGs in astrocytes, but CSPG's influence on autophagy and its role in SCI remain unclear.
Purpose of the Study:
- To investigate the effects of intracellular sigma peptide (ISP), which targets PTPσ, on autophagy and synaptic reorganization in the context of SCI.
- To elucidate the therapeutic potential of ISP in promoting recovery after spinal cord injury.
Main Methods:
- Utilized western blotting to assess autophagy markers (LC3B-II/I, p62) and autophagosome-lysosome fusion proteins (STX17, LAMP2).
- Quantified pre- and post-synaptic markers (SYN, PSD-95, VGLUT1), axon markers (neurofilament, GAP-43), and motor neuron survival.
- Evaluated neurobehavioral recovery in an SCI model.
Main Results:
- ISP treatment activated autophagy flux by increasing LC3B-II/I and decreasing p62.
- ISP restored autophagosome-lysosome fusion, evidenced by increased STX17 and LAMP2 levels.
- ISP enhanced synaptic reorganization, promoted axon growth, preserved motor neurons, and improved neurobehavioral outcomes in SCI models.
Conclusions:
- ISP targeting PTPσ activates autophagy flux, facilitates synaptic reorganization, and promotes functional recovery after SCI.
- ISP demonstrates therapeutic potential for mitigating SCI pathology and enhancing recovery by influencing CSPG-PTPσ signaling and autophagy.
More Related Videos
Related Concept Videos
Neurogenesis and Regeneration of Nervous Tissue
Postsynaptic Potential (PSP)
There are two types of receptors: ionotropic and metabotropic.
The ionotropic receptor is the membrane protein that has an...
Long-term Potentiation
Hebbian LTP
LTP can occur when...

